- Cdc20 (Cell Division Cycle 20) is a highly conserved cell‑cycle protein that plays a central role in controlling the onset of anaphase. As a co‑activator of the APC/C, Cdc20 ensures that cells do not separate their sister chromatids until all chromosomes are correctly attached to the mitotic spindle. This makes Cdc20 a crucial guardian of genomic integrity. Its activity is tightly regulated by checkpoint mechanisms, phosphorylation events and protein–protein interactions that collectively determine whether a cell can safely proceed through mitosis.
- During metaphase, sister chromatids are held together by cohesin complexes. Cdc20 activates APC/C, which ubiquitinates securin and Cyclin B, marking them for proteasomal degradation. The destruction of securin releases separase, an enzyme that cleaves cohesin and allows chromatids to separate. At the same time, Cyclin B degradation inactivates CDK1, enabling cells to exit mitosis. Without Cdc20, APC/C remains inactive, securin persists, and anaphase cannot begin. Thus, Cdc20 functions as the molecular switch that commits the cell to chromosome segregation.
- Cdc20 activity is tightly controlled by the spindle assembly checkpoint (SAC), a surveillance system that prevents anaphase until all chromosomes achieve proper bipolar attachment. SAC proteins such as Mad2, BubR1 and Bub3 bind to Cdc20 to form the mitotic checkpoint complex (MCC). This inhibitory complex blocks APC/C activation, ensuring that premature chromosome separation does not occur. Only when all kinetochores are correctly attached does the SAC silence, releasing Cdc20 to activate APC/C. This checkpoint‑dependent regulation makes Cdc20 indispensable for preventing aneuploidy.
- Beyond its canonical role in mitosis, Cdc20 has broader implications in cell‑cycle control and disease. In rapidly dividing cells, Cdc20 expression is tightly linked to proliferation. Its levels rise during late G2 and peak in mitosis, reflecting its role in driving cell‑cycle transitions. In developmental contexts, Cdc20 ensures accurate cell division in tissues where precise chromosome segregation is essential for differentiation and organ formation.
- Cdc20 is also strongly associated with cancer biology. Many tumours exhibit overexpression of Cdc20, which correlates with high proliferation rates, chromosomal instability and poor clinical outcomes. Excessive Cdc20 activity can override checkpoint controls, allowing cells with misaligned chromosomes to proceed through mitosis, thereby generating aneuploid progeny. Conversely, insufficient Cdc20 activity can cause mitotic arrest, leading to apoptosis or senescence. Because of its central role in mitotic fidelity, Cdc20 is being explored as a potential therapeutic target. Inhibiting Cdc20 or disrupting its interaction with APC/C may selectively impair tumour cells that rely on rapid, error‑prone division.
- At the molecular level, Cdc20 contains WD40 repeats that facilitate substrate recognition and binding to APC/C. Phosphorylation by mitotic kinases such as Aurora A and Plk1 modulates its activity, while interactions with checkpoint proteins determine whether it acts as an activator or remains inhibited. This multilayered regulation ensures that Cdc20 functions only when the cell is fully prepared for chromosome segregation.
- In summary, Cdc20 is a master regulator of the metaphase‑to‑anaphase transition, acting through APC/C to initiate chromosome separation and mitotic exit. Its precise regulation by the spindle assembly checkpoint protects cells from genomic instability, while its dysregulation contributes to tumour progression. As research advances, Cdc20 continues to emerge as a critical node linking cell‑cycle control, checkpoint signalling and cancer biology.
